
Senseonics Holdings SENS
€ 5.78
0.75%
Senseonics Holdings Zahlungsmittel | SENS
Zahlungsmittel Jährlich Senseonics Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.2 M | 74.6 M | 75.7 M | 35.8 M | 33.5 M | 18 M | 95.9 M | 137 M | 16.2 M | 13 M | 3.94 M | 18.9 M | 8.25 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 137 M | 3.94 M | 43.9 M |
Zahlungsmittel Vierteljährlich Senseonics Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.6 M | 34.5 M | 31.5 M | 39.3 M | 74.6 M | 27.4 M | 35.2 M | 90.9 M | 75.7 M | 55.8 M | 28.6 M | 45.1 M | 35.8 M | 35.5 M | 45.4 M | 39 M | 33.5 M | 46.2 M | 69.8 M | 179 M | 18.2 M | 18 M | 18 M | 18 M | 95.9 M | 95.9 M | 95.9 M | 95.9 M | 137 M | 137 M | 137 M | 137 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 13 M | 13 M | 13 M | 13 M | 3.94 M | 3.94 M | 3.94 M | 3.94 M | 18.9 M | 4.42 K | 10 K | 4.42 K | 8.25 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 179 M | 4.42 K | 45.2 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
11.3 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
531 K | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
920 M | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
1.42 M | - | -1.84 % | $ 15.3 M | ||
|
Quotient Limited
QTNT
|
65.1 M | - | -11.32 % | $ 1.1 M | ||
|
T2 Biosystems
TTOO
|
15.7 M | - | -39.35 % | $ 313 K | ||
|
Renalytix AI plc
RNLX
|
4.68 M | - | 5.66 % | $ 22.7 M | ||
|
Syneos Health
SYNH
|
112 M | - | - | $ 4.46 B | ||
|
Meridian Bioscience
VIVO
|
81.5 M | - | - | $ 1.49 B | ||
|
Surmodics
SRDX
|
36.1 M | - | - | $ 608 M | ||
|
Agilent Technologies
A
|
1.79 B | $ 127.06 | 2.2 % | $ 36.1 B | ||
|
Anixa Biosciences
ANIX
|
1.24 M | $ 2.91 | 8.18 % | $ 94.4 K | ||
|
Biodesix
BDSX
|
19 M | $ 16.81 | 10.45 % | $ 127 M | ||
|
Biomerica
BMRA
|
2.4 M | $ 1.79 | -9.14 % | $ 4.11 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.14 | -1.72 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
478 M | $ 7.25 | 2.98 % | $ 76.5 M | ||
|
Bioventus
BVS
|
51.2 M | $ 8.71 | 1.99 % | $ 580 M | ||
|
Brainsway Ltd.
BWAY
|
69.3 M | $ 14.89 | 3.33 % | $ 506 M | ||
|
CareDx, Inc
CDNA
|
65.4 M | $ 26.18 | 11.5 % | $ 1.4 B | ||
|
Celcuity
CELC
|
166 M | $ 87.76 | -0.33 % | $ 4.1 B | ||
|
Co-Diagnostics
CODX
|
11.9 M | $ 3.37 | 1.2 % | $ 4.48 M | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 185.0 | 1.46 % | $ 9.17 B | ||
|
Castle Biosciences
CSTL
|
117 M | $ 21.12 | 4.3 % | $ 612 M | ||
|
Quest Diagnostics Incorporated
DGX
|
420 M | $ 195.0 | -1.4 % | $ 21.6 B | ||
|
Danaher Corporation
DHR
|
4.62 B | $ 177.17 | -0.33 % | $ 126 B | ||
|
DarioHealth Corp.
DRIO
|
21.8 M | $ 6.93 | -2.81 % | $ 27.6 M | ||
|
DexCom
DXCM
|
918 M | $ 72.47 | 1.74 % | $ 28.3 B | ||
|
Fulgent Genetics
FLGT
|
50.2 M | $ 18.0 | 1.69 % | $ 554 M |